Influence
October 21, 2020

COVID-19 and the ICU: Regenstrief expert shares experience providing care for patients

Indiana University Center for Aging Research at Regenstrief Institute Associate Director Babar Khan, M.D., M.S., has been treating patients in the intensive care unit (ICU) throughout the COVID-19 pandemic.

Dr. Khan said many patients continue to suffer from mental, physical and emotional impairments after being released from the ICU, and those problems can persist for months. He shared his experience with national media, including Kaiser Health News.

He reported that older adults in the ICU with COVID-19 are suffering from delirium 70 to 80 percent of the time. Seniors are especially susceptible to delirium, which is a sudden change in brain function, when they are hospitalized for serious illnesses. Delirium in older adults is associated with an increased risk of losing independence, developing dementia and death.

Dr. Khan said given the extent of delirium and mounting evidence of neurological damage from COVID-19, he expects to see an increase in the prevalence of ICU-acquired cognitive impairment.

Even younger patients may face a long recovery after time spent in the ICU.

Dr. Khan helped develop the critical care recovery center model, dedicated to long-term recovery from intensive care. He works with patients at Eskenazi Health after they have been discharged from the ICU to help them recover from physical, emotional and mental symptoms that continue to linger.

Dr. Khan and his colleagues are also conducting research to prevent, diagnose and treat delirium.

Read about cognitive impairment in COVID-19 survivors

Listen to Dr. Khan discuss ICU recovery in an episode of The Problem podcast from Regenstrief.

In addition to his role at Regenstrief, Dr. Khan also serves as an associate professor of medicine at Indiana University School of Medicine and a physician at Eskenazi Health.

Related News

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

Regenstrief one of the partners expected to drive advancements and commercialization in biosciences  Regenstrief Institute will partner with Indiana

Thomas Imperiale, MD

Is the Multitarget Stool DNA Test Just a Better “FIT” for Colorectal Cancer Screening?

Published in the journal JAMA Internal Medicine. Here is a link to the article. Regenstrief Institute authors: Tom Imperiale,

Alexia Torke, MD, MS, and George Fitchett, DMin, PhD

Caring for the emotional and spiritual needs of family members of ICU patients

INDIANAPOLIS – Family members of intensive care unit (ICU) patients often experience psychological and spiritual distress as they deal

Randall Grout, MD

Informaticians apply tools and techniques to eliminate ambiguity and better implement guidelines and policies in pediatric care

Policy implementation experts’ model can be reproduced and repeated, in many different practices For the last three decades, medical